Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) agreed to acquire 16.33% stake in Surgimatix, Inc for $3.1 million on February 20, 2024. The transaction is expected to complete by the end of February 2024 and is subject fulfilment of certain conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,511 INR | -0.52% | +0.31% | +19.98% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B | |
-2.27% | 4.81B | |
+6.69% | 4.72B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Limited agreed to acquire 16.33% stake in Surgimatix, Inc for $3.1 million.